Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic eval...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-09-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/8/4/166 |
| _version_ | 1818932567368269824 |
|---|---|
| author | Emily A. F. Holmes Dyfrig A. Hughes |
| author_facet | Emily A. F. Holmes Dyfrig A. Hughes |
| author_sort | Emily A. F. Holmes |
| collection | DOAJ |
| description | The threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation. |
| first_indexed | 2024-12-20T04:34:32Z |
| format | Article |
| id | doaj.art-90b01b68f0a64199b2ae039145b074e9 |
| institution | Directory Open Access Journal |
| issn | 2079-6382 |
| language | English |
| last_indexed | 2024-12-20T04:34:32Z |
| publishDate | 2019-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Antibiotics |
| spelling | doaj.art-90b01b68f0a64199b2ae039145b074e92022-12-21T19:53:17ZengMDPI AGAntibiotics2079-63822019-09-018416610.3390/antibiotics8040166antibiotics8040166Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial ResistanceEmily A. F. Holmes0Dyfrig A. Hughes1Centre for Health Economics and Medicines Evaluation (CHEME), Bangor University, Normal Site, Bangor, Gwynedd LL57 2PZ, UKCentre for Health Economics and Medicines Evaluation (CHEME), Bangor University, Normal Site, Bangor, Gwynedd LL57 2PZ, UKThe threat of antimicrobial resistance has global health and economic consequences. Medical strategies to reduce unnecessary antibiotic prescribing, to conserve the effectiveness of current antimicrobials in the long term, inevitably result in short-term costs to health care providers. Economic evaluations of health care interventions therefore need to consider the short-term costs of interventions, to gain future benefits. This represents a challenge for health economists, not only in terms of the most appropriate methods for evaluation, but also in attributing the potential budget impact over time and considering health impacts on future populations. This commentary discusses the challenge of accurately capturing the cost-effectiveness of health care interventions aimed at tackling antimicrobial resistance. We reflect on methods to capture and incorporate the costs and health outcomes associated with antimicrobial resistance, the appropriateness of the quality-adjusted-life year (QALY), individual time preferences, and perspectives in economic evaluation.https://www.mdpi.com/2079-6382/8/4/166antimicrobial resistanceeconomic evaluationcost-utility analysiscost-effectiveness analysisantibiotics |
| spellingShingle | Emily A. F. Holmes Dyfrig A. Hughes Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance Antibiotics antimicrobial resistance economic evaluation cost-utility analysis cost-effectiveness analysis antibiotics |
| title | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
| title_full | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
| title_fullStr | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
| title_full_unstemmed | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
| title_short | Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance |
| title_sort | challenges for economic evaluation of health care strategies to contain antimicrobial resistance |
| topic | antimicrobial resistance economic evaluation cost-utility analysis cost-effectiveness analysis antibiotics |
| url | https://www.mdpi.com/2079-6382/8/4/166 |
| work_keys_str_mv | AT emilyafholmes challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance AT dyfrigahughes challengesforeconomicevaluationofhealthcarestrategiestocontainantimicrobialresistance |